T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma

Leuk Lymphoma. 2000 Apr;37(3-4):387-91. doi: 10.3109/10428190009089439.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology*
  • Female
  • Humans
  • Immunization, Passive
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / pathology*
  • Lymphoma, B-Cell / immunology*
  • Lymphoma, B-Cell / pathology
  • Lymphoma, B-Cell / therapy*
  • Middle Aged
  • Rituximab
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / pathology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Rituximab